Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy (multiple letters) [10]

Lancet

Volumn 350, Issue 9077, 1997, Pages 588-590

  Mitchell, S M ^a   Youle, M S ^a   Membrey, W L ^a   Jones, C D ^a   Uthayakumar, S ^a   Birthistle, K ^a   Dalton, R ^a   Hay, P E ^a   Stricker, R B ^a   Goldberg, B ^a   Carr, A ^a   Cooper, D A ^a   Stein, D S ^a   Jacobson, M A ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GANCICLOVIR; INDINAVIR; MARKER; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; LETTER; LONG TERM CARE; LYMPHOCYTE COUNT; OPHTHALMOLOGY; PRIORITY JOURNAL; RELAPSE; REMISSION; RETINITIS; SYMPTOM; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS RETINITIS; IMMUNOLOGY; NOTE; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS RETINITIS; HIV INFECTIONS; HUMANS; ADULT; FEMALE; REMISSION INDUCTION; VIRAL LOAD;

EID: 0030832402     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26034-4     Document Type: Letter

References (5)

1. MA Jacobson M Zegrans PR Pavan Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy Lancet 349 1997 1443 1445
2. DS Stein DG Fish JA Bilello A 24 week open-label Phase 1/2 evaluation of the HIV protease inhibitor MK-639 (indinavir) AIDS 10 1996 485 492
3. C Rinaldo XL Huang P Piazza Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients J Infect Dis 164 1991 638 645
4. M Clerici AL Landay HA Kessler Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus infected patients J Infect Dis 166 1992 723 730
5. DS Stein GL Drusano Modeling of the change in CD4 lymphocyte counts in patients before and after administration of the human immunodeficiency virus protease inhibitor indinavir Antimicrob Agents Chemother 41 1997 449 453